Transporter |
Synonyms |
Inhibitor |
IC50 (μM) |
Ki (μM) |
Substrate used |
Cell System |
Reference |
ABCB1 |
MDR1, P-gp |
Nicardipine |
6.6 |
|
Calcein AM |
NIH-3T3-G185 cells |
Wang, 2001 |
ABCB1 |
MDR1, P-gp |
Nicardipine |
2.3 |
|
Calcein AM |
MDR1 expressing LLC-PK1 cells |
Schwab, 2003 |
mouse_Abcb1a |
Mdr, Pgp, Pgy, Mdr3, P-gp, Abcb4, Mdr1a |
Nicardipine |
2.5 |
|
Calcein AM |
Mouse mdr1a expressing LLC-PK1 cells |
Schwab, 2003 |
mouse_Abcb1b |
mdr, Mdr1, Pgy1, Abcb1, Mdr1b, Pgy-1 |
Nicardipine |
8 |
|
Calcein AM |
Mouse mdr1b expressing LLC-PK1 cells |
Schwab, 2003 |
ABCB1 |
MDR1, P-gp |
Nicardipine |
4.8 |
|
Calcein AM |
MDR1 expressing A2780/ADR cells |
Muller, 2007 |
ABCB1 |
MDR1, P-gp |
Nicardipine |
17.5 |
|
Daunorubicin |
MDR1 expressing LLC-PK1 cells |
Katoh, 2000 |
ABCB1 |
MDR1, P-gp |
Nicardipine |
3.2 |
|
Daunorubicin |
NIH-3T3-G185 cells |
Wang, 2001 |
ABCB1 |
MDR1, P-gp |
Nicardipine |
4.5 |
|
Digoxin |
MDR1 expressing LLC-PK1 cells |
Takara, 2002 |
ABCC4 |
MRP4 |
Nicardipine |
88 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
ABCC2 |
MRP2, cMOAT |
Nicardipine |
>133 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
ABCC3 |
MRP3 |
Nicardipine |
>133 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
ABCB1 |
MDR1, P-gp |
Nicardipine |
14.6 |
|
Fluo-3 |
NIH-3T3-G185 cells |
Wang, 2001 |
ABCB1 |
MDR1, P-gp |
Nicardipine |
4.8 |
|
Hoechst 33342 |
MDR1 expressing A2780/ADR cells |
Pick, 2008 |
ABCB1 |
MDR1, P-gp |
Nicardipine |
7.1 |
|
JC-1 |
NIH-3T3-G185 cells |
Wang, 2001 |
ABCB1 |
MDR1, P-gp |
Nicardipine |
5.6 |
|
LDS-751 |
NIH-3T3-G185 cells |
Wang, 2001 |
ABCB1 |
MDR1, P-gp |
Nicardipine |
25.8 |
|
Rhodamine 123 |
NIH-3T3-G185 cells |
Wang, 2001 |
ABCB11 |
BSEP |
Nicardipine |
7.87 |
|
Taurocholate |
Sf9 cell membrane vesicles |
Morgan, 2013 |
ABCB1 |
MDR1, P-gp |
Nicardipine |
11.7 |
|
Tetramethylrosamine |
NIH-3T3-G185 cells |
Wang, 2001 |
No drug-drug interaction information.